The present study investigated serum FGF19, BA, and C4 profiles in overweight and obese NAFLD patients, in comparison to normal-weight healthy controls, after a body weight-adjusted oral fat load. The gene discussed is FGF19; the disease is metabolic dysfunction-associated steatotic liver disease.